- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NuCana Announces Completion of ADS Ratio Change
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
- NuCana Announces Plan to Implement ADS Ratio Change
- NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
- NuCana to Present at TD Cowen’s 44th Annual Health Care Conference
- NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update
More ▼
Key statistics
As of last trade NuCana PLC (NCNA:NAQ) traded at 3.66, 7.64% above its 52-week low of 3.40, set on Apr 19, 2024.
52-week range
Open | 3.55 |
---|---|
High | 3.86 |
Low | 3.54 |
Bid | 3.55 |
Offer | 3.63 |
Previous close | 3.59 |
Average volume | 23.30k |
---|---|
Shares outstanding | 84.58k |
Free float | 36.50k |
P/E (TTM) | -- |
Market cap | 7.59m USD |
EPS (TTM) | -302.31 USD |
Data delayed at least 15 minutes, as of May 23 2024 18:11 BST.
More ▼